LYPHOMED LMED SELLS CONVERTIBLE DEBENTURES NEW YORK March LyphoMed Inc is raising mln dlrs through an offering of convertible subordinatred debentures due with a pct coupon and par pricing said lead manager Alex Brown and Sons Inc The debentures are convertible into the company s common stock at dlrs per share representing a premium of pct over the stock price when terms on the debt were set Non callable for two years the issue is rated BB by Standard and Poor s Corp Montgomery Securities co managed the deal Reuter